Table 1
Differences in population characteristic between women with BMI<25 (control samples) and BMI>25 (case samples). *p<0.001 against control group (BMI<25)
| BMI<25 | BMI>25 | |
|---|---|---|
| Patients n° (%) | 15 (41) | 22 (59) |
| BMI (media±SD) | 22±1.9 | 29±3.4* |
| Age years (media±SD) | 57±10.8 | 59±7.88 |
| Smoker (%) | 13 | 13.6 |
| physical activity (%) | 33 | 31.8 |
| Pregnancies (%) | 80 | 90 |
Figure 1
Distribution of population in relation to the time away from menopause. a) BMI<25; b) BMI>25
Figure 2
Distribution of population in relation to the time of onset; a) menarche age >13; menopause age <38.
Table 2
Differences in percent of patients that had physiological level of SFA, MUFA, PUFA, n-6/n-3 PUFA between control group (BMI<25) and case group (BMI>25).
| BMI<25 | BMI>25 | ||
|---|---|---|---|
| range | % patients | % patients | |
| SFA | 30-45 | 80 | 68 |
| MUFA | 13-23 | 33 | 45 |
| PUFA | 28-39 | 27 | 59 |
| n-6PUFA/n3 PUFA | 3,5-5,5 | 47 | 27 |
Table 3
Differences in percent of patients that had physiological level of SFA, MUFA, PUFA, n-6/n-3 PUFA between case group and control group.
| BMI<25 | BMI>25 | ||||
|---|---|---|---|---|---|
| range | %<5 years | %>5years | %<5 years | %>5years | |
| SFA | 30-45 | 89 | 67 | 60 | 75 |
| MUFA | 13-23 | 33 | 33 | 40 | 50 |
| PUFA | 28-39 | 22 | 33 | 50 | 67 |
| n-6PUFA/n3 PUFA | 3,5-5,5 | 33 | 67 | 0 | 50 |
Figure 3
SFA, MUFA, and PUFA levels in control group (a) and case group (b).
Figure 4
n-6/n-3PUFA ratio value in control group (a) and case group (b). *p<0.001 against n-6/n-3PUFA <5.